Could Albuminuria Be an Overlooked Marker of Thrombotic Risk? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Xiu Hong Yang et al, adding:
”Could albuminuria be an overlooked marker of thrombotic risk?
We usually think of the urine albumin-to-creatinine ratio (UACR) as a kidney or cardiovascular marker.
But what if it also reflects systemic thrombotic vulnerability?
A new prospective RPTH study of 419,282 UK Biobank participants examined the relationship between albuminuria and future arterial thromboembolism (ATE) and pulmonary embolism (PE).
Here’s the key signal:
- Moderate albuminuria (UACR 3–30 mg/mmol) increased ATE risk
- Severe albuminuria (>30 mg/mmol) increased the risk of both ATE and c
- Risk intensified further with reduced kidney function or low serum albumin
What’s changing under the hood:
- Albuminuria reflects endothelial dysfunction and vascular injury
- Associated with platelet activation and hypercoagulability
- Linked to inflammatory pathways (CRP, VWF, ADAMTS13)
- Suggests a systemic prothrombotic state – not just kidney disease
(Figures 1–3 show dose-dependent increases in thrombotic risk with rising UACR)
Translation:
Albuminuria may not simply mark renal injury; it may identify patients with heightened endothelial and thrombotic dysfunction.
Big questions for the field:
- Should UACR be incorporated into thrombosis risk assessment?
- Is albuminuria a mediator of thrombosis – or a marker of systemic vascular injury?
- Could aggressive treatment of albuminuria reduce thromboembolic events?”
Title: Urine albumin-to-creatinine ratio and risks of incident arterial thromboembolism and pulmonary embolism among adults—a prospective cohort study
Authors: Xiu Hong Yang, Yao Liu, Zhen Xing Zhang, Yi Jun Lu, Chen Sheng Fu, Hui Min Jin, Zhi Bin Ye, Xiao Li Zhang

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 16:04Monia Ezzalfani: Advancing Patient-Centered Care in Hemophilia A and B
-
Sep 23, 2026, 15:49Bilge Başak: How Activated PRP Modulates Osteoarthritic Chondrocyte Function
-
Sep 23, 2026, 14:50Mbonjo Bitsie Dora: Strengthening Sickle Cell Care Through Education, Awareness and Innovation
-
Sep 23, 2026, 13:58The New B12 Diagnostic Algorithm: From Serum Cobalamin to Functional Deficiency
-
Sep 23, 2026, 13:56Noha Soror: Preparing for Hematology and Medical Oncology Board Certification
-
Sep 23, 2026, 13:46Ugochi Ogu: What Can Platelet Proteomics Reveal about Pain and Neurocognitive Vulnerability in Sickle Cell Disease?
-
Sep 23, 2026, 13:42Melissa Hollo: Connecting Obesity and Anemia for Earlier Maternal Risk Intervention
-
Sep 23, 2026, 13:16Beverley Hunt: Advances in Haemostatic Management of Postpartum Haemorrhage
-
Sep 23, 2026, 13:13Ioanna Mela: Recruiting a Research Associate on DNA nanotechnology